back to open calls

Biomedical Catalyst 2022 Round 1: Industry-led R&D

Opens:
28/3/2022
Closes:
25/5/2022
Sectors:
Health & Life Sciences
Project Size:
Between £150k and £4million

Innovate UK, part of UK Research and Innovation, will invest up to £15million in projects to support UK-registered businesses to develop innovative health or healthcare-focused products, technologies and processes.

Your project can focus on:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures
  • the development of digital health technologies

This list is not intended to be exhaustive.

The Industry-led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility.

Your project must:

  • have total project costs between £150,000 and £4million
  • not exceed a grant request of £2 million
  • have at least 50% of the total project costs shared by the SMEs, if collaborative
  • start by 1 December 2022
  • end by 30 November 2025
  • last between 6 months and 36 months
  • carry out all of its project work in the UK
  • intend to exploit the results from or in the UK

You must only include eligible project costs in your application. If you have requested an overall grant of over £500,000, and your online application is successful at Stage 1, you may be invited to attend an interview

To lead a project or work alone your organisation must be a UK registered micro, small or medium-sized enterprise (SME).

To collaborate with the lead, your organisation must be one of the following UK registered:

  1. business of any size
  2. academic institution
  3. charity
  4. not for profit
  5. public sector organisation
  6. research and technology organisation (RTO)

Each partner organisation must be invited into the Innovation Funding Service by the lead to collaborate on a project. Once accepted, partners will be asked to login or to create an account and enter their own project costs into the Innovation Funding Service.

Partners must accept terms and conditions (T&C’s) and complete the subsidy question in order for the application to be submitted.

For collaborations, the lead and at least one other organisation must claim funding by entering their costs during the application.

Your project can include partners that do not receive any of this competition’s funding, for example non-UK businesses. Their costs will count towards the total project costs.

Subcontractors are allowed in this competition.

Subcontractors can be from anywhere in the UK and you must select them through your usual procurement process.

You can use subcontractors from overseas but must make the case in your application as to why you could not use suppliers from the UK.

You must provide a detailed rationale, evidence of the potential UK contractors you approached and the reasons why they were unable to work with you. We will not accept a cheaper cost as a sufficient reason to use an overseas subcontractor.

All subcontractor costs must be justified and appropriate to the total project costs. Extenuating circumstances where overseas work may be allowable include, for example; clinical trial in a specific patient population.

An SME can only lead on one application but can be included as a collaborator in a further two applications.

If an SME is not leading on any application, it can collaborate in any number of applications.

An RTO, a large business, academic institution, charity, not for profit, or public sector organisation can collaborate on any number of applications.

The aim of this industry-led R&D competition is to support the development of innovative solutions to health and healthcare challenges.

We will only support innovation projects conducted to the highest standards of animal welfare.

Visit the UKRI Good Research Hub and NC3R’s animal welfare guidance for further information.

Your project can include:

  • experimental evaluation (at laboratory scale)
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • a demonstration of clinical utility and effectiveness
  • a demonstration of safety and efficacy (including phase 1 and 2 clinical trials)
  • regulatory planning

Innovate UK want to fund a variety of projects across different technologies, markets, technological maturities and research categories. This is called a portfolio approach.

Equality, diversity and inclusion (EDI) considerations are highly encouraged where appropriate in the proposal. Applications will continue to be assessed on their innovation merit, where innovation is defined as the potential for commercially successful exploitation of ideas.

Your project can focus on any health or healthcare sector or discipline.

The Biomedical Catalyst now incorporates the Digital Health Technology Catalyst and will support digital health projects.

Your project can align with one or more of the following Innovation areas:

  • biosciences
  • advanced therapies (gene and cell therapies)
  • diagnostic, medical technology and devices
  • digital health
  • independent living and wellbeing
  • precision medicine
  • preclinical technologies and drug target discovery
  • therapeutic and medicine development

This list is not intended to be exhaustive.

Interested in this call? Book a free consultation with our team
Book a Consultation
+44 (0) 1925 506 100
Contact Us
Thank you! We will be in touch shortly.
Oops! Something went wrong while submitting the form.